Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
ALKS News
Alkermes plc (ALKS) has disclosed a new risk, in the Corporate Activity and Growth category. Elevate Your Investing Strategy: Take advantage of TipRanks Premi...
BofA analyst Jason Gerberry raised the firm’s price target on Alkermes (ALKS) to $34 from $33 and keeps a Neutral rating on the shares following what the firm c...
Joseph Thome, an analyst from TD Cowen, maintained the Buy rating on Alkermes. The associated price target was raised to $40.00. Elevate Your Investing Strategy...
Analyst ratings
80%
of 15 ratingsMore ALKS News
Alkermes (ALKS) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.73...
(RTTNews) - Alkermes plc (ALKS) released earnings for third quarter that Dropped, from the same period last year The company's earnings came in at $82.76 milli...
Alkermes plc ((ALKS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unl...
Alkermes plc ((ALKS)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unl...